Rankings
▼
Calendar
XENE
Xenon Pharmaceuticals Inc.
$5B
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$9M
Operating Income
-$12M
Net Income
-$11M
EPS (Diluted)
$-0.44
QoQ Revenue Growth
-100.0%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$491,000
Balance Sheet
Total Assets
$115M
Total Liabilities
$22M
Stockholders' Equity
$92M
Cash & Equivalents
$52M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$9M
-$6M
-64.1%
Operating Income
-$12M
-$8M
-50.4%
Net Income
-$11M
-$4M
-202.0%
← FY 2019
All Quarters
Q2 2019 →
XENE Q1 2019 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena